The Role of the Microbiota-gut-brain Axis in Brain Development and Mental Health
Launched by UNIVERSITY OF SURREY · Feb 7, 2019
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
Anxiety disorders are debilitating conditions that carry enormous individual, social and economic costs. For example, it has been estimated that lifelong persistent mental health problems cost the UK taxpayer £8.6 billion annually. Many mental health problems have their onset in the transitional period from adolescence to early adulthood, possibly a result of the complex and concurrent hormonal, genetic, brain maturational and social changes during this period. Research has shown that brain development and maturation extends well into the third decade of life and that brain activation patte...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females
- • Aged between 18-25
- Exclusion Criteria:
- • Clinical levels of anxiety and/ or co-morbid diagnoses (e.g. depression)
- • Current or previous neurological disorders
- • Current or previous psychiatric disorders
- • Current or previous gastrointestinal disorders
- • Current or previous endocrine disorders
- • Antibiotic use 3 months prior to the study
- • Regular use of pre- and probiotics, including 3 months prior to the study
- • Vegan diets
About University Of Surrey
The University of Surrey is a leading research institution located in the United Kingdom, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on multidisciplinary collaboration, the university fosters an environment that encourages cutting-edge studies across various fields, including medicine, health sciences, and technology. The University of Surrey actively engages in clinical trials aimed at exploring new therapeutic approaches, enhancing patient care, and contributing to the global body of medical knowledge. Its state-of-the-art facilities and expertise in clinical research methodology ensure rigorous study design and ethical standards, making it a valuable partner in the pursuit of scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guildford, Surrey, United Kingdom
Patients applied
Trial Officials
Kathrin Cohen Kadosh, PhD
Principal Investigator
University of Surrey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials